Amylyx Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (AMLX)

171 filings reported holding AMLX - Amylyx Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share as of Q2 2025.
Amylyx Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (AMLX) has 130 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 81.7M shares of 111M outstanding shares and own 73.74% of the company stock.
Largest 10 shareholders include ADAGE CAPITAL PARTNERS GP, L.L.C. (8.8M shares), PERCEPTIVE ADVISORS LLC (7.9M shares), TCG Crossover Management, LLC (5.94M shares), BlackRock, Inc. (5.51M shares), Point72 Asset Management, L.P. (4.54M shares), VANGUARD GROUP INC (4.5M shares), Saturn V Capital Management LP (3.26M shares), FMR LLC (3.05M shares), Nantahala Capital Management, LLC (2.93M shares), and 683 Capital Management, LLC (2.16M shares).
This table shows the top 130 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.